These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 6440181)

  • 21. Enhancement of hypophysectomy-induced dopamine receptor hypersensitivity in male rats by chronic haloperidol administration.
    Gordon JH; Diamond BI
    J Neurochem; 1984 Feb; 42(2):523-8. PubMed ID: 6537969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of chronic treatments with SM-9018, a potential atypical neuroleptic, on behavioral dopaminergic and serotonergic sensitivities in rats.
    Ohno Y; Ishida K; Ishibashi T; Ikeda K; Kato T; Nakamura M
    Gen Pharmacol; 1995 May; 26(3):489-94. PubMed ID: 7789721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrophysiological and behavioral assessments of dopamine autoreceptor activation to apomorphine in rats.
    Okuyama S; Shimamura H; Hashimoto S; Aihara H
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):246-54. PubMed ID: 3827410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of thioridazine on haloperidol induced behavioral hypersensitivity.
    Klawans HL; Carvey PM; Nelson D; Tanner CM; Goetz CG
    Life Sci; 1986 May; 38(19):1707-14. PubMed ID: 3702600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine.
    Sayers AC; Bürki HR; Ruch W; Asper H
    Psychopharmacologia; 1975; 41(2):97-104. PubMed ID: 1171492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of stereotypy induced by nomifensine in rats during continuous chronic haloperidol treatment.
    Rupniak NM; Jenner P; Marsden CD
    Neurosci Lett; 1984 Sep; 50(1-3):63-5. PubMed ID: 6541767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation.
    Carvey PM; Hitri A; Goetz CG; Tanner CM; Klawans HL
    Life Sci; 1988; 42(22):2207-15. PubMed ID: 3374255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haloperidol, but not apomorphine, differentially affects low response rates of male and female Wistar rats.
    Van Hest A; van Haaren F; van de Poll NE
    Pharmacol Biochem Behav; 1988 Mar; 29(3):529-32. PubMed ID: 3362947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroleptic-induced emotional defecation: effects of pimozide and apomorphine.
    Sanberg PR
    Physiol Behav; 1989 Aug; 46(2):199-202. PubMed ID: 2602459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrastriatal injection of kainic acid prevents the development of postsynaptic dopamine receptor hypersensitivity after chronic haloperidol treatment.
    Zarkovsky AM; Nurk AM; Rägo LK; Allikmets LH
    Neuropharmacology; 1982 Feb; 21(2):155-8. PubMed ID: 7199630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged antidopaminergic actions of single doses of butyrophenones in the rat.
    Campbell A; Baldessarini RJ; Teicher MH; Kula NS
    Psychopharmacology (Berl); 1985; 87(2):161-6. PubMed ID: 3931140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioural subsensitivity induced by long-term administration of a low dose of haloperidol to rats.
    Frussa-Filho R; Abílio VC; Bergamo M; Palermo-Neto J
    J Pharm Pharmacol; 1997 Apr; 49(4):412-5. PubMed ID: 9232539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of buspirone on dopamine dependent behaviours in rats.
    Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
    Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of anticholinergics and clozapine on the activation of the striatal dopaminergic system in the rat by haloperidol. Pharmacological findings (author's transl)].
    Sayers AC; Bürki HR
    Arzneimittelforschung; 1976; 26(6):1092-3. PubMed ID: 989384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.
    Pittman KJ; Jakubovic A; Fibiger HC
    Psychopharmacology (Berl); 1984; 82(4):371-7. PubMed ID: 6427831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clozapine fails to prevent the development of haloperidol-induced behavioral hypersensitivity in a cotreatment paradigm.
    Carvey PM; Nath ST; Kao LC; Zhang TJ; Lin DH; Singh R; Amdur RL; Klawans HL
    Eur J Pharmacol; 1990 Aug; 184(1):43-53. PubMed ID: 2209714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
    Bartoszyk GD; Harting J; Minck KO
    J Pharmacol Exp Ther; 1996 Jan; 276(1):41-8. PubMed ID: 8558454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of dihydroergotoxine on some dopamine-related behaviors in rats.
    Flório JC; Palermo-Neto J
    Gen Pharmacol; 1990; 21(4):411-5. PubMed ID: 2379797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol.
    Seeger TF; Thal L; Gardner EL
    Psychopharmacology (Berl); 1982; 76(2):182-7. PubMed ID: 6805029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic haloperidol treatment potentiates apomorphine- and ethanol-induced hypothermia in the rat.
    Lai H; Kazi MS; Carino MA; Horita A
    Life Sci; 1982 Mar; 30(10):821-6. PubMed ID: 7200179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.